BlackRock’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.2M | Buy |
|
|||||
|
2025
Q1 | $42.7M | Buy |
|
|||||
|
2024
Q4 | $57.2M | Buy |
|
|||||
|
2024
Q3 | $68.9M | Buy |
|
|||||
|
2024
Q2 | $67.7M | Buy |
|
|||||
|
2024
Q1 | $1.29M | Sell |
|
|||||
|
2023
Q4 | $1.15M | Buy |
|
|||||
|
2023
Q3 | $808K | Buy |
|
|||||
|
2023
Q2 | $880K | Buy |
|
|||||
|
2023
Q1 | $432K | Buy |
|
|||||
|
2022
Q4 | $274K | Buy |
|
|||||
|
2022
Q3 | $171K | Buy |
|
|||||
|
2022
Q2 | $70K | Sell |
|
|||||
|
2022
Q1 | $251K | Buy |
|
|||||
|
2021
Q4 | $242K | Buy |
|
|||||
|
2021
Q3 | $293K | Buy |
|
|||||
|
2021
Q2 | $165K | Sell |
|
|||||
|
2021
Q1 | $4.6M | Sell |
|
|||||
|
2020
Q4 | $3.9M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.12M | Sell |
|
|||||
|
2018
Q2 | $2.99M | Sell |
|
|||||
|
2018
Q1 | $3.73M | Sell |
|
|||||
|
2017
Q4 | $4.61M | Sell |
|
|||||
|
2017
Q3 | $6.12M | Buy |
|
|||||
|
2017
Q2 | $5.8M | Sell |
|
|||||
|
2017
Q1 | $5.26M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $21K | Buy |
|